X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Wockhardt Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Wockhardt Quarterly Results   (WOCK)

Here are the latest quarterly results of Wockhardt. For more details, see the Wockhardt financial fact sheet and Wockhardt share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Wockhardt Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-16
*
3
Sep-16
*
3
Dec-16
*
3
Mar-17
*
3
Jun-17
*
3
Sep-17
*
3
Dec-17
*
3
Mar-18
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m10,90810,6479,9568,6358,91110,22310,05310,183 
Other income Rs m7019953563370546371-84 
Turnover Rs m10,97810,84610,0089,1989,28110,76810,42410,099 
Expenses Rs m10,0569,6529,77410,2789,51110,0109,58610,244 
Gross profit Rs m8449161,770-1,318-4,183213467-45 
Depreciation Rs m364374381371372362380382 
Interest Rs m486564614589611676618650 
Profit before tax Rs m65178827-1,715-4,795-279-160-1,160 
Tax Rs m-948-15733-170-191265352 
Profit after tax Rs m159170984-1,747-4,626-88-426-1,513 
Gross profit margin %7.78.617.8-15.3-46.92.14.6-0.4 
Effective tax rate %-145.64.3-19.0-1.93.568.4-165.8-30.4 
Net profit margin %1.51.69.9-20.2-51.9-0.9-4.2-14.9 
Diluted EPS Rs 1.4 1.5 8.9 -15.9 -42.0 -0.8 -3.9 -13.7  
Diluted EPS (TTM) Rs 19.2 12.4 15.8 -3.9 -47.4 -49.8 -62.6 -60.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   UNICHEM LAB  SUN PHARMA  NATCO PHARMA  ALEMBIC LTD  STRIDES SHASUN LTD  

Compare WOCKHARDT LTD. With:   UNICHEM LAB  SUN PHARMA  NATCO PHARMA  ALEMBIC LTD  STRIDES SHASUN LTD  

Compare WOCKHARDT LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Tata Steel & Vedanta Top Losers(Closing)

Indian share markets erased early gains to end lower today, as the opposition parties tabled a no-confidence motion against Prime Minister Narendra Modi's government.

Views on news

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

How to Avoid a 90% Loss Suffered by This Super Investor(The 5 Minute Wrapup)

Jul 12, 2018

Blindly following super investors is a dangerous game to play. Here's how you can avoid such mistakes.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

New Fund Offer - ICICI Prudential Pharma Healthcare and Diagnostics Fund - Should You Invest?(Outside View)

Jul 6, 2018

ICICI AMC launches an open -ended equity fund following Pharma, Healthcare, Diagnostic and allied theme.

When Disappointment Panda is Around. Buy Quality Stock like This!(Chart Of The Day)

Jul 6, 2018

Buy Companies that can fight all kinds of Pandas and Bears in the long run.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WOCKHARDT LTD. SHARE PRICE


Jul 18, 2018 03:37 PM

TRACK WOCKHARDT LTD.

  • Track your investment in WOCKHARDT LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON WOCKHARDT LTD.

WOCKHARDT LTD. - ADCOCK INGRAM COMPARISON

COMPARE WOCKHARDT LTD. WITH

MARKET STATS